Indacaterol
CQAB149BHK02
Approved small_molecule completed
Quick answer
Indacaterol for Chronic Obstructive Pulmonary Disease is a Approved program (small_molecule) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Chronic Obstructive Pulmonary Disease
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed